Table 2 Assessment of diabetic status and drug regimen among the study participants
Diabetes assessment | Frequency (N) | Percentage (%) |
|---|---|---|
Diabetes type | ||
Type 1 | 3 | 3.6 |
Type 2 | 80 | 95.2 |
Unspecified | 1 | 1.2 |
Year(s) of diagnosis | ||
< 10 years | 47 | 58 |
11–20 years 21 years and above | 29 5 | 35.8 6.2 |
Co-morbidity/ Systemic DM | ||
complications | 28 | 33.3 |
Hypertension | 12 | 14.3 |
DM-foot ulcer | 6 | 7.1 |
Kidney disease | 6 | 7.1 |
Hyperosmolar hyperglycemic state | 2 | 2.4 |
Erectile dysfunction | 5 | 6.0 |
Cellulitis | 1 | 1.2 |
Ocular dysfunction | 1 | 1.2 |
Thyroid dysfunction | 3 | 3.6 |
Retroviral disease | 20 | 23.8 |
Nil | ||
Anti- diabetes regimen | ||
Insulin alone | 15 | 18.5 |
Insulin + oral agents | 22 | 27.2 |
Metformin alone | 17 | 21.0 |
Metformin + Sulfonylurea | 25 | 30.9 |
Metformin + DPP4 inhibitors | 2 | 2.5 |